Sign in

CIK 0001641281

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Bolt Biotherapeutics, Inc.

Sign in to watch
Ticker
BOLT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472804636
Phone
+1 650-665-9295
Business address
900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Former names
Bolt Therapeutics, Inc.
Open-market buys, last 90 days
$628,922
in 2 filings
Open-market sales, last 90 days
$128,281
in 3 filings

Net +$500,641. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-06-04 Quinn William P. Chief Financial Officer Purchase +1,221 $16.65 $20K 15,119
2021-02-09 Novo Holdings A/S 10% owner Purchase +400,000 $20.00 $8.0M 4,503,991
2021-02-09 Vivo Capital VIII, LLC 10% owner Purchase +175,733 $20.00 $3.5M 1,997,216
2021-02-09 Vivo Capital VIII, LLC 10% owner Purchase +24,267 $20.00 $485K 275,789
2021-02-09 Vivo Capital VIII, LLC 10% owner Purchase +150,000 $20.00 $3.0M 150,000
2021-02-09 LAPORTE KATHLEEN Director Purchase +1,200 $20.00 $24K 1,200
2021-02-09 HEALY JAMES Director Purchase +450,000 $20.00 $9.0M 2,754,437
2021-02-09 Khanna Ashish Siri Ram Director Purchase +1,000 $20.00 $20K 1,000
2021-02-09 Khanna Ashish Siri Ram Director Purchase +1,200 $20.00 $24K 1,200
2021-02-09 ENGLEMAN EDGAR Director Purchase +175,733 $20.00 $3.5M 1,997,216
2021-02-09 ENGLEMAN EDGAR Director Purchase +24,267 $20.00 $485K 275,789
2021-02-09 Quinn William P. Chief Financial Officer Purchase +1,200 $20.00 $24K 13,898
2021-02-09 Schatzman Randall C Chief Executive Officer Purchase +1,500 $20.00 $30K 1,500
2021-02-09 Sofinnova Venture Partners X, L.P. 10% owner Purchase +450,000 $20.00 $9.0M 2,754,437

Page 2 of 2 · 34 trades